PATENT CLAIM ANALYSIS

Application Number: 16175915
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["546", "064000"]

Abstract:
The invention described herein pertains to selective Janus kinase (JAK) inhibitors and methods of use thereof. Also described are methods for treating diseases involved abnormal JAK/STAT signaling pathway in mammals using the described selective JAK inhibitors or a pharmaceutical formulation thereof.

Claim (Index 17):
A method for treating diseases mediated by abnormal JAK/STAT pathway, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders, comprising the step of administering a therapeutically effective amount of one or more compounds of  claim 1 , in combination with one or more other compounds of the same or different mode of action, and one or more carriers, diluents, or excipients, to a patient in need of relief from said disease.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 1.21622
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15973569', '15144311', '14111157', '14110391', '14119673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7660487694940114
- 35 USC 102 Novelty (BERT): 0.5570844562450481
- Combined Prediction Score: 0.7451523381691151
- Mean Citation Score: 361.95723
- Max Citation Score: 446.05054
- Similarity Product: 314.8118084679436

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test